2. GPCR/G Protein
  3. RXFP Receptor
  4. AZ7976

AZ7976 (Compound 42) is a highly selective agonist for the Relaxin Family Peptide Receptor 1 (RXFP1) (pEC50 > 10.5). AZ7976 enhances RXFP1's cAMP signaling through an allosteric mechanism, thereby physiologically increasing heart rate. AZ7976 can be used in the field of cardiovascular disease research.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

AZ7976

AZ7976 Chemische Struktur

CAS. Nr. : 2813866-27-0

Größe Verfügbarkeit
50 mg   Angebot einholen  
100 mg   Angebot einholen  
250 mg   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

AZ7976 Related Antibodies

Top Publications Citing Use of Products

  • Biologische Aktivität

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

Beschreibung

AZ7976 (Compound 42) is a highly selective agonist for the Relaxin Family Peptide Receptor 1 (RXFP1) (pEC50 > 10.5). AZ7976 enhances RXFP1's cAMP signaling through an allosteric mechanism, thereby physiologically increasing heart rate. AZ7976 can be used in the field of cardiovascular disease research[1].

Cellular Effect
Cell Line Type Value Description References
HepG2 IC50
17 μM
Compound: 42
Cytotoxicity against human HepG2 cells cultured as C3a spheroids assessed as reduction in cell viability
Cytotoxicity against human HepG2 cells cultured as C3a spheroids assessed as reduction in cell viability
[PMID: 38502780]
HepG2 IC50
37 μM
Compound: 42
Cytotoxicity against human HepG2 cells cultured under galactose condition assessed as reduction in cell viability
Cytotoxicity against human HepG2 cells cultured under galactose condition assessed as reduction in cell viability
[PMID: 38502780]
HepG2 IC50
68 μM
Compound: 42
Cytotoxicity against human HepG2 cells cultured under glucose condition assessed as reduction in cell viability
Cytotoxicity against human HepG2 cells cultured under glucose condition assessed as reduction in cell viability
[PMID: 38502780]
THP-1 IC50
15 μM
Compound: 42
Cytotoxicity against human THP-1 cells assessed as reduction of cell viability incubated for 48 hrs by resazurin reduction assay
Cytotoxicity against human THP-1 cells assessed as reduction of cell viability incubated for 48 hrs by resazurin reduction assay
[PMID: 38502780]
In Vitro

AZ7976 (48h) has a cytotoxicity of IC50=15 μM (THP1), 68/37 μM (HepG2 Glu/Gal), and 17 μM (HepG2 C3a spheroids). AZ7976's inhibitory effects on BSEP, hERG, NaV1.5, and KaV4.3 (Ikr) are IC50=23 μM (BSEP), >39 μM (hERG), 231 μM (NaV1.5), and >33 μM (KaV4.3 (Ikr)), respectively. In the A549 micronucleus test, it shows negative genotoxicity[1].
AZ7976 (90 min; concentration responses) does not compete with relaxin H2 for binding to RXFP1 in CHO-hRXFP1 cells, but enhances 125I-relaxin H2 binding[1].
AZ7976 inhibits ion channels and bile salt efflux transporter (BSEP) and is cytotoxic to THP1[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

AZ7976 Related Antibodies
In Vivo

AZ7976 (i.v.; initial 1.5 mg/kg; i.v.drip; continuous 9.0 mg/kg) causes a significant increase in heart rate and a rise in mean arterial blood pressure in the rats.[1].

Pharmacokinetic Analysis in AZ7976[1]

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Route Dose (μmol/kg) Vdss (L/kg) Cl (mL/min/kg) t1/2 (h) oral dose (μmol/kg) F (%)
i.v. 0.73 2.3 38 2.9 1.46 11
Animal Model: Sprague-Dawley rats[1]
Dosage: initial 1.5 mg/kg, continuous 9.0 mg/kg
Administration: i.v.; i.v.drip
Result: Caused a significant increase in heart rate and a rise in mean arterial blood pressure in the rats, the same response in Sprague-Dawley rats as after RXFP1 receptor activation
Molekulargewicht

682.65

Formel

C30H33F7N2O6S
CAS. Nr.
SMILES

COC1=CC(F)=C(C=C1C(N[C@H]2[C@H]([C@@H]3CC[C@H]2C3)C(NC4=CC=C(C(S(F)(F)(F)(F)F)=C4)F)=O)=O)O[C@H]5CC[C@](C)(CC5)C(O)=O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

AZ7976 Related Classifications

  • Molaritätsrechner

  • Verdünnungsrechner

Die Formel zur Berechnung von Molaritäten

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)

Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

AZ79762813866-27-0AZ 7976AZ-7976RXFP ReceptorRelaxin family peptideRXFP1 AgonistCardiovascular EffectsAllosteric ModulationInhibitorinhibitorinhibit

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Produktname

  

Requested Quantity *

Name des Antragstellers *

 

Anrede

E-Mail-Addresse *

 

Telefonnummer *

Department

 

Name der Organisation *

City

Bundesland

Country or Region *

      

Bemerkungen

Massenanfrage

Inquiry Information

Produktname:
AZ7976
Art. -Nr.:
HY-162401
Menge:
MCE Japan Authorized Agent:

Kundenbewertung

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Produktname

  

Lot #

Name des Antragstellers *

 

E-Mail-Addresse *

Telefonnummer

 

Department *

Name der Organisation *

 

Country or Region *

Bemerkungen

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.